Login / Signup

Electromotive Drug Administration Chemotherapy with Mitomycin C Versus Bacillus Calmette-Guerin for the Treatment of Non-Muscle Invasive Bladder Cancer.

María Teresa Melgarejo SeguraAna Morales MartínezYaiza Yáñez CastilloMiguel Ángel Arrabal PoloFrancisco Gutiérrez TejeroManuel Pareja VílchezMiguel Arrabal
Published in: Bladder cancer (Amsterdam, Netherlands) (2023)
No differences were found between MMC-EMDA and BCG treatments in patients with high-risk and intermediate-risk NMIBC without CIS.
Keyphrases
  • muscle invasive bladder cancer
  • drug administration
  • locally advanced
  • squamous cell carcinoma
  • radiation therapy
  • replacement therapy